4//SEC Filing
ROBERTS EIRY 4
Accession 0000914475-24-000226
CIK 0000914475other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:47 PM ET
Size
7.9 KB
Accession
0000914475-24-000226
Insider Transaction Report
Form 4
ROBERTS EIRY
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2024-12-17+5,487→ 5,487 total→ Common Stock (5,487 underlying) - Award
Stock Option
2024-12-17+27,770→ 27,770 totalExercise: $136.69Exp: 2034-12-17→ Common Stock (27,770 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
- [F2]The Restricted Stock Units will vest 1/4 of the units on February 13, 2025, and then annually 1/4 of the shares will vest on February 13, 2026, February 13, 2027, and February 13, 2028.
- [F3]Represents an option of which 1/4 of the shares underlying the option becomes vested and exercisable on February 13, 2025 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter beginning on March 13, 2025, such that the option shall fully vest on February 13, 2028.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001727606
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:47 PM ET
- Size
- 7.9 KB